Biomarkers in and of Critical Illness: What do they mean and are they useful? Rand Butcher CNC Intensive Care & Coronary Care The Tweed Hospital

Similar documents

Acute coronary syndrome. Dr LM Murray Chemical Pathology Block SA

ΒΙΟΔΕΙΚΤΕΣ ΣΤΗΝ ΚΑΡΔΙΑΚΗ ΑΝΕΠΑΡΚΕΙΑ. ΔΗΜΗΤΡΙΟΣ ΤΟΥΣΟΥΛΗΣ Καθηγητής Καρδιολογίας

Chemistry Reference Ranges and Critical Values

Chemistry Reference Ranges and Critical Values

Biomarkers in cardiovascular disease. Felix J. Rogers, DO, FACOI April 29, 2018

Use of surrogate inflammatory markers in the diagnosis & monitoring of patients with severe sepsis

EDUCATIONAL COMMENTARY CARDIAC FUNCTION: BIOCHEMICAL MARKERS UPDATE

To estimate the serum level of N-terminal pro-brain natriuretic peptide levels in acute coronary syndrome

CERTIFICATE OF ACCREDITATION

The Usefulness of Sepsis Biomarkers. Dr Vineya Rai Department of Anesthesiology University of Malaya

Biomarkers of myocardial infarction. Dr. Mamoun Ahram Cardiovascular system, 2013

Current Utilities of Cardiac Biomarker Testing at POC. June 24, 2010 Joe Pezzuto, MT (ASCP) Carolyn Kite, RN

Essam Mahfouz, MD. Professor of Cardiology, Mansoura University

Doppler ultrasound, see Ultrasonography. Magnetic resonance imaging (MRI), kidney oxygenation assessment 75

Laboratory diagnosis of heart diseases: Cardiometabolic risk AMI Heart failure

TROPONIN POSITIVE 2/20/2015 WHAT DOES IT MEAN? When should a troponin level be obtained?

CERTIFICATE OF ACCREDITATION

NEW RCPCH REFERENCE RANGES-

Protocol Identifier Subject Identifier Visit Description. [Y] Yes [N] No. [Y] Yes [N] N. If Yes, admission date and time: Day Month Year

Myocardial injury, necrosis and infarction

Acute Coronary Syndrome

Understanding Blood Tests

Heart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output

Continuing Medical Education Post-Test

Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association

Post Operative Troponin Leak: David Smyth Christchurch New Zealand

Routine Clinic Lab Studies

Updates in Congestive Heart Failure

The Universal Definition of Myocardial Infarction 3 rd revision, 2012

BIOMARKERS IN SEPSIS

The ACC Heart Failure Guidelines

2016 ESC Guidelines for the Diagnosis and treatment of Acute & Chronic Heart Failure

Βιοδείκτες στην καρδιακή ανεπάρκεια διαγνωστικά και θεραπευτικά δεδομένα. Χριστίνα Χρυσοχόου Επιμ Α Α Παν. Καρδιολογικής Κλινικής, ΙΓΝΑ

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice

Epic Labs Orderable As STAT PRIORITY As of 06/22/2016

CERTIFICATE OF ACCREDITATION

Test Result Reference Range Flag

Classification of lab tests useful in cardiac disease Biochemical markers in Acute Coronary Syndromes (ACS) Redefinition of Myocardial Infarction (MI)

Acute heart failure in a patient with lower urinary tract infection Case report of an infection-induced Reverse Takotsubo syndrome

Dear Valuable Readers, Thank you for the support

LOKUN! I got stomach ache!

JMSCR Vol 05 Issue 01 Page January 2017

Copeptin in heart failure: Associations with clinical characteristics and prognosis

Proceedings of the 36th World Small Animal Veterinary Congress WSAVA

Tables of Normal Values (As of February 2005)

COPD Common disease associated with HF

Ischemic Heart Disease

Severe Hypertension. Pre-referral considerations: 1. BP of arm and Leg 2. Ambulatory BP 3. Renal causes

ROTUNDA HOSPITAL DEPARTMENT OF LABORATORY MEDICINE

Cardiac Pathology & Rehabilitation

Complete Medical History

High Sensitivity Troponins. IT S TIME TO SAVE LIVES. Updates from the ESC 2015 Guidelines November 17th 2016 OPL CONGRESS Dr.

Heart Failure and Cardio-Renal Syndrome 1: Pathophysiology. Biomarkers of Renal Injury and Dysfunction

Physiological Response to Hypovolemic Shock Dr Khwaja Mohammed Amir MD Assistant Professor(Physiology) Objectives At the end of the session the

Cardiovascular Disease in CKD. Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center

NT-proBNP: Evidence-based application in primary care

Ruolo dei Marcatori Bioumorali nello scompenso cardiaco

Assessment and Diagnosis of Heart Failure

ICL Integrative Laboratory Services Test Menu Contact ICL Client Care x300

6/29/2017. Role of Biomarkers in the Management of Heart Failure Patients. What s New in Biomarkers for HF Patients?

CEDR 2018 QCDR Measures for CMS 2018 MIPS Performance Year Reporting

Measuring Natriuretic Peptides in Acute Coronary Syndromes

Review of Cardiac Imaging Modalities in the Renal Patient. George Youssef

6. Production or formation of plasma protein and clotting factors and heparin.

John Park, MD Assistant Professor of Medicine

Trial to Reduce. Aranesp* Therapy. Cardiovascular Events with

CERTIFICATE OF ACCREDITATION

Pro-enkephalin and Renal Disease. Alan H. Wu, Ph.D. University of California, San Francisco 12 th Annual UCSD Biomarkers of Cardiac Disease

Οξεία καρδιακή ανεπάρκεια: Ποιες παράμετροι συμβάλλουν στη διαστρωμάτωση κινδύνου των ασθενών;

Pre Hospital and Initial Management of Acute Coronary Syndrome

Supplement Table 1. Definitions for Causes of Death

Lnformation Coverage Guidance

Acute coronary syndromes

Cardiorenal and Renocardiac Syndrome

Cardiac arrhythmias. Janusz Witowski. Department of Pathophysiology Poznan University of Medical Sciences. J. Witowski

The Who, How and When of Advanced Heart Failure Therapies. Disclosures. What is Advanced Heart Failure?

Takotsubo syndrome. Ευτυχία Σμπαρούνη, FACC, FESC

Biomarkers and Arrhythmias/Devices Ulrika Birgersdotter-Green, M.D.

Non-Ischemic Causes of Troponin Elevation: Getting It Right. March 28, 2015

Acute Coronary Syndromes: Challenges to Management. Claire Williams November 2017

Chronic Hepatic Disease

Περικαρδίτιδα στην καρδιακή ανεπάρκεια

Supplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.

Hamilton Regional Laboratory Medicine Program

Hamilton Regional Laboratory Medicine Program

Product: Omecamtiv Mecarbil Clinical Study Report: Date: 02 April 2014 Page 1

ECMO: a breakthrough in care for respiratory failure. PD Dr. Thomas Müller Regensburg no conflict of interest

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases

2010 ACLS Guidelines. Primary goals of therapy for patients

Chapter 5: Sepsis Stephen Lo

DOWNLOAD PDF ABC OF HEART FAILURE

ROUTINE LAB STUDIES. Routine Clinic Lab Studies

UPDATES IN MANAGEMENT OF HF

Lec: 21 Biochemistry Dr. Anwar J Almzaiel. Clinical enzymology. Very efficient can increase reaction rates at the order of x 10

WSLH. Calibration Verification/ Linearity Products. roficiency. esting. Products provided in partnership with:

Topic. Updates on Definition of Myocardial Infarction

POSTGRADUATE INSTITUTE OF MEDICINE UNIVERSITY OF COLOMBO

Transcription:

Biomarkers in and of Critical Illness: What do they mean and are they useful? Rand Butcher CNC Intensive Care & Coronary Care The Tweed Hospital Northern NSW Local Health District

Definition i i of a Biomarker A biochemical feature or facet that can be used to diagnose and/or measure the progress of disease or the effects of treatment.

Content Cardiac biomarkers Troponin (I, T, & C) / CKMB B type Natriuretic Peptide (BNP) Sepsis Procalcitonin AKI creatinine, urea, new biomarkers Liver failure Liver enzymes Brain failure Neuron specific enolase PE D dimer Clotting APTT / INR

Cardiac Biomarkers MI biomarkers -Troponin / CK, CKMB Heart failure biomarkers - BNP

Biomarkers of Myocardial Infarction

Basis of Injury Severe acute ischaemia: lowers the resting potential (makes it less negative) Shortens the duration of the action potential and changes the shape of the plateau (phase 2) in the ischaemic area. Phase 1 0 mv Phase 0-90mV Phase 4 Phase 2

WHO definition i i of MI 2 of 3 of the following criteria Typical symptoms Typical ECG changes Elevated cardiac biomarker

Case studies

36 year old female 3 day history of shortness of breath Flu like symptoms Decline in exercise tolerance Generalised malaise Fevers Presents to the ED with chest pain

Sent to PCI facility Angiogram NAD Raised Troponin I Met all 3 of the WHO criteria for an MI Chest pain p ST elevation Raised troponin

84 year old female 4 day history productive cough Chest x-ray lobular consolidation Treated with ceftriaxone of course Noted to be between the flags Heart rate 93 Respiratory rate 22 WCC low Temp 35.8 o C Raised troponin diagnosed as non STEMI

ECG

Case 1 36 year old female

The trouble with biomarkers

Other conditions can alter the ST segment / T wave Electrolyte abnormalities Post-cardiac surgical state Anemia Fever Acidosis or alkalosis Catecholamines Drugs Acute abdominal process Endocrine abnormalities Metabolic changes Cerebrovascular accidents Diseases such as myocarditis, pericarditis, cardiomyopathy, pulmonary emboli infections amyloidosis systemic diseases lung diseases emboli, infections, amyloidosis, systemic diseases, lung diseases Abnormal T waves and ST segments may also be seen in healthy individuals, including well trained athletes.

The trouble with biomarkers Can t rely on the ECG Can t rely on troponin

The Ideal Biochemical Cardiac Marker High Sensitivity - High concentration of the marker in the myocardium High specificity- it Absent concentrations ti in non cardiac tissue and not detectable in blood from non-diseased subjects Release rapid release for early diagnosis and long half life in the blood for early diagnosis Analytical l cost effective, short turn around time, precise, accurate Clinical ability to influence therapy and so improve patient outcomes, validated by clinical studies.

Troponin

Troponin Specific to cardiac tissue 3 types of troponin Takes 6-12 hours to be excreted Stays in your blood for 10-14 days

WHO definition i i of MI 2 of 3 of the following criteria Typical symptoms Typical ECG changes Elevated CKMB The addition of Troponin testing demonstrated that approximately half the number of patients did not meet the WHO criteria with a raised troponin More ACS patients with MI

Troponin T and Mortality

Positive Troponins in the Critically Ill Commonly (always) raised in the ICU population p The sensitivity of Troponin is high in patients presenting with signs of acute coronary syndrome The sensitivity of troponin in ICU has been quoted to be in the range of 56%.?????????????

Pericarditis & myocardities 30% have raised troponin / CKMB PCI CKMB & Troponin raised post procedure, prognostic indicator. Heart failure troponin elevated and is a prognostic indicator PE troponin elevated. Amount correlates with degree of ventricular dysfunction and prognosis. Renal failure troponin elevated, increased risk of death Sepsis elevated. Not prognostic indicator Critical Illness - elevated. Not prognostic indicator Acute stroke elevated predict mortality but link with ACS.

The role of echocardiography in establishing: the diagnosis, location, extent of MI, in diagnosing mechanical complications of infarction, providing prognostic information that is important for risk stratification will be reviewed

RWMA s changes occur prior to the onset of electrocardiographic changes or the development of symptoms Regional myocardial dysfunction, which can be detected as regional wall motion abnormalities on echocardiography, occurs before ECG changes or anginal chest pain. Beller, GA, Am J Cardiol 1988; 61:22F

AUSabia P; Afrookteh A; Touchstone DA; Keller MW, Kaul Esquivel L,S SO, 1991, Value of regional wall motion abnormality in the emergency room diagnosis i of acute myocardial infarction. A prospective study using two-dimensional echocardiography.circulation Sep;84(3 Suppl):I85-92 92. Thus, echocardiography for an acute coronary syndrome has a high sensitivity but a relatively lower specificity. Study of 180 patients with chest pain in the emergency department; the following findings were noted RWMAs were present in 27 of 29 patients with an acute MI (sensitivity 93 %) (only 9 had ST elevation and 8 developed q waves) RWMAs were indicative of acute MI in only 31 percent of 87 patients

Role of Troponin in the Critically Ill Useful in diagnosing MI in patients presenting with signs of ACS when you can use the WHO criteria Limited role in the critically ill Flags patients who may require an echo

BNP

BNP in Adult Cardiac Disease Widely used as a biomarker in the distinction between dyspnea yp caused by congestive heart failure and that caused by non cardiac aetiologies 1. 1. Maisal, A.S. Krishnaswamy, P, Nowak, RM, et al 2002, Rapid measurement of B-Type natriuretic peptide in the emergency diagnosis peptide in the emergency diagnosis of heart failure N Enl J Med 347:161-167.

BNP In 1988 Sudoh & colleagues described a novel natriuretic a) peptide in porcine brain 1 (Brain Natriuretic Peptide) Subsequently found to be most abundant in the heart renamed B-type Natriuretic Peptide (BNP) Release is triggered in large part by myocyte b) stretch BNP levels ls are easily quantified by several commercial assays. 1. Sudoh, t. Kangawa, L, Minamino, N, Matsuo H, (1988), A new natriutetic peptide in porcine brain. Nature 332: 78-81. a) An agent that promotes the excretion of sodium in the urine b) Cardiac muscle cell.

Pi Primary actions Vascular smooth muscle relaxation and anti-mitogenesis 1 Mediated by cgmp, diuresis caused by a shift of fluid into the interstium and Naturiuresis, caused by antagonism of renin and aldosterone release. 1. Mitogenesis = the initiation of the process of cell division, or mitosis.

NP Pathway Pre-Pro BNP Pro BNP NT pro BNP BNP NT-ProBNP is BNP may be a excreted by the better dynamic kidneys thus renal measure e as the half function has a life is shorter (20 greater influence on NT-proBNP levels min vs 60-120 mins) than BNP levels.

In addition to volume and pressure loading: Acute myocardial ischaemia Alpha agonist stimulation Endothelin-1 and inflammatory mediators, such as: Tumor necrosis factor (TNF) alpha and interleukin (IL) beta Result in a rapid ventricular expression of BNP

Role of BNP in the Critically Ill 1. Maisal, A.S. Krishnaswamy, P, Nowak, RM, et al 2002, Rapid measurement of B-Type natriuretic peptide in the emergency diagnosis peptide p in the emergency diagnosis of heart failure N Enl J Med 347:161-167.

Procalcitonin

Cytokines Pro inflammatory Tubular Necrosis Factor α (TNF α) Interleukin 1 (IL1) Interleukin 1β (IL β) Interleukin 2 (IL2) Interleukin 6 (IL6) Anti inflammatory Interleukin 4 (IL4) Interleukin n 10(IL10) 0) Interleukin 13 (IL 13)

Sepsis and Septic Shock Early signs of sepsis (fever, leukocytosis) are non specific. More specific signs (lactate, hypotension) are late and associated with a high mortality Variety of biomarkers have been proposed: Cytokines (IL6 & IL8) Acute phase proteins (such as CRP) Procalcitonin

Procalcitonin (PCT) Procalcitonin is a peptide of 114 aminoacids, lacking the N-terminal dipeptide alanine-proline. line pivotal roles in the metabolic and inflammatory host response to microbial infections Role in calcium homeostasis Levels elevated in the setting of bacterial sepsis

High PCT may exert harmful effects influencing mortality and morbidity: PCT injected into healthy hamsters causes minor changes in phosphate, calcium and glucose. 1 PCT injected into septic hamsters increases mortality to almost 100%. 1 Immunoneutralisation ameliorates symptomatology and improves outcome 1 1. Nylen ES, Whang KT, Snider RH Jr, et al: Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis Crit Care Med 1998; 26:1001 1006

Future

Role of Procalcitonin in the ICU Variable results from reviews and metanalysis May assist with diagnosis Other conditions apart from bacterial sepsis and septic shock may cause an elevated PCT Serial measurements may assist in prognosis, monitoring i course of disease, and antibiotic description

Acute Kidney Injury

Bowman s Capsule

Creatinine Urea NGAL

Rifle Criteria i

Liver Function Tests

1) Enzyme tests Serum aminotransferases alanine aminotransferase (ALT), and aspartate aminotransferase (AST). alkaline phosphatase and alkaline phosphatase, and gamma glutamyl transpeptidase

Function of the Liver Storage, manufacturing and cleansing of blood Storage of many nutrients including: vitamins A, D, E, K and B 12 trace minerals such as iron and copper Manufactures bile, albumin and clotting factors Cleansing the blood of toxins and bacteria

Complications of Liver Failure Hepatic encephalopathy h Variceal bleeding infection

2) tests of synthetic function principally the serum albumin principally the serum albumin concentration and prothrombin time

3) liver's ability to detoxify metabolites and transport organic anions into bile Bilirubin

4) Blood flow & hepatic function Indocyanine green dye clearance

Brain Damage

Neuron specific enolase

Pulmonary Emboli

D Dimer

Clotting

INR APTT

Biomarkers in the critically ill No current clinical biomarker is perfect Troponin has a low sensitivity in the critically ill. Role of BNP limited to the ED differientiating cause of respiratory failure PCT? Best available biomarker for sepsis but do no inject PCT into septic hamsters Creatinine / Urea best available Liver +ve D dimer not useful APTT - INR